HCI Group Inc (NYSE: HCI) stock closed at $78.38 on 11/8/23 after a major increase of 21.5%. The stock has risen 32.9% during the last week and has been strong relative to the market over […]
B. Riley Financial Inc (NASDAQ: RILY) has reported a loss for its third fiscal quarter (ending September 30) of $-2.53 versus $1.62 for the same period a year ago — a decline of -256%. E.P.S. […]
Perrigo Co Plc (NYSE: PRGO) has reported E.P.S. of $0.11 for its third fiscal quarter (ending September 30) versus $-0.39 for the same period a year ago. This performance was $-0.50 short of the consensus […]
HomeStreet Inc (NASDAQ: HMST) stock closed at $5.74 on 11/7/23 after a major decline of -11.4%. The stock has risen 25.6% during the last week but has been extremely weak relative to the market over […]
On 11/7/23, PRA Group Inc (NASDAQ: PRAA) stock enjoyed a major increase of 16.6%, closing at $16.89. Relative to the market the stock has been extremely weak over the last nine months but has risen […]
On 11/7/23, Ameresco Inc (NYSE: AMRC) stock suffered a major decline of -14.9%, closing at $22.65. The stock has been weak relative to the market over the last nine months and has declined -18.0% during […]
Axon Enterprise Inc (NASDAQ: AXON) has reported earnings for its third fiscal quarter (ending September 30) of $0.79 versus $0.17 for the same period a year ago — an increase of 365%. This performance was […]
Surgery Partners Inc (NASDAQ: SGRY) has reported E.P.S. of $-0.04 for its third fiscal quarter (ending September 30) versus $-0.28 for the same period a year ago. This result fell short of the consensus estimate […]
Innospec Inc (NASDAQ: IOSP) has reported earnings for its third fiscal quarter (ending September 30) of $1.58 versus $1.56 for the same period a year ago — an increase of 1%. This result exceeded the […]
Ingredion Inc (NYSE: INGR) has reported E.P.S. of $2.39 for its third fiscal quarter (ending September 30) versus $1.61 for the same period a year ago — an increase of 48%. Relative to the consensus […]
Privacy Statement Terms Of Use ©2024 PriceTarget Research